MondayMay 12, 2025 9:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Announces $100 Million Project Financing from CIM Group for U.S. Solar Expansion

SolarBank and CIM Group have announced a US$100 million financing deal for a portfolio of U.S. solar energy projects totaling 97 MW. The deal is structured as a preferred equity investment at the project level, preserving SolarBank’s share capital, with CIM receiving a 3% annual coupon and retaining full ownership of transferred investment tax credits. SolarBank expects to maintain majority ownership of the 21-project portfolio post-financing, supporting SolarBank’s shift toward becoming a long-term solar asset owner in the U.S. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable…

Continue Reading

ThursdayMay 08, 2025 9:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 7.2 MW Glor Rd Community Solar Project in Upstate New York

SolarBank plans to develop a 7.2 MW DC ground-mount solar project in upstate New York, part of a growing pipeline of SolarBank developments in the area. The project will operate under a community solar model, with customer acquisition managed by Solar Simplified, and is expected to power approximately 850 homes. In addition, the new development will participate in New York’s VDER rate program and may qualify for NYSERDA incentives. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar…

Continue Reading

WednesdayMay 07, 2025 10:00 am

Is the US Ready as China’s EV Industry Seeks to Dominate Global Markets?

The just-concluded Shanghai Auto Show 2025 showcased China's incredible advancements in battery electric vehicle technology. While most governments in the West have been relatively slow to adopt EVs, Beijing began pumping tens of billions of dollars in subsidies into the domestic electric vehicle sector well over a decade ago, giving its industry a major head start over carmakers in other markets. As a result, China has surpassed the U.S. and Europe to become the largest electric vehicle market on the globe. Its gargantuan population provides a massive market for its homegrown electric cars, and unlike Western carmakers, Chinese vehicle companies…

Continue Reading

MondayMay 05, 2025 10:00 am

Gold Bulls Lose Steam as Rate Cut Expectations Rise

Rising expectations of a benchmark interest rate cut by the U.S. Federal Reserve are causing gold prices to fall. With numerous investors betting that the Fed would cut interest rates after the U.S. registered weaker-than-expected growth in the first quarter of 2025, spot gold and gold futures prices experienced some losses on Wednesday. Spot gold prices fell by 0.2% to reach $3,308.32 per ounce, and U.S. gold futures dropped by 0.4% and settled at $3,319.10. Additionally, data shows that in Q1 2025, America's gross domestic product contracted at an annualized rate of 0.3% as businesses in the country scrambled to…

Continue Reading

FridayMay 02, 2025 9:00 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Expands Portfolio with Additional Solar Project in Upstate New York

SolarBank is developing a 4.584 MW DC ground-mount solar project in upstate New York, projected to power 540 homes. The Forest Hill Rd project will operate under New York’s community solar framework and benefit from VDER compensation and NYSERDA incentives. Solar Simplified will handle subscriber management, allowing SolarBank to focus on development and expansion. The company is not presently importing solar panels from the four countries impacted by the April 21, 2025, U.S. Department of Commerce Tariff announcement. Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and…

Continue Reading

WednesdayApr 30, 2025 10:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Committed to Advancing Cancer Care with Innovative RTNova Platform Research

Cancer statistics underscore the urgency of ongoing cancer research and the need for more effective cancer treatments. Calidi Biotherapeutics has announced preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The trials show an ability to deliver therapeutic payloads with precision while simultaneously attacking tumors. Cancer remains one of the deadliest diseases worldwide. Globally, the World Health Organization reports that the number of deaths will surpass 9.7 million in 2024, with a projected 20 million new cancer cases diagnosed; WHO also noted that it anticipates the cancer burden increasing an estimated 77% by…

Continue Reading

TuesdayApr 29, 2025 10:00 am

America to Slap 3,521% Tariff on Solar Energy Panels Made in Southeast Asia

The United States government is taking steps to protect its domestic solar equipment industry from being overwhelmed by major players from East Asia. Over the past decade, countries in East Asia have significantly boosted solar panel output, becoming some of the largest producers in the world. With the U.S. planning a major transition to renewables, their dominance threatens the survival of America's domestic solar industry. As a response, the U.S. Commerce Department has announced plans to impose import tariffs reaching a maximum of 3,521% on all solar panels originating from four Southeast Asian countries. The announcement follows a year-long investigation…

Continue Reading

TuesdayApr 29, 2025 9:00 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Reports Innovative RTNova Platform Research, Exemplifies Pivotal Role of Research

“Research on the treatment of cancer is fundamental to improving outcomes for all patients affected by the disease,” reports the National Cancer Institute. CLDI is reporting preclinical results for its systemic RTNova platform, which has successfully delivered transient gene therapy payloads to targeted tumors. “With this breakthrough, we can use our platform to develop multiple assets for various indications,” says CEO. Cancer remains one of the most formidable health challenges worldwide, necessitating relentless research to uncover effective treatments. Continuous scientific inquiry has led to groundbreaking therapies, offering hope to millions. A recent development in this arena is Calidi Biotherapeutics’ (NYSE…

Continue Reading

MondayApr 28, 2025 10:00 am

India Unveils First System Leveraging Quantum Computing

An Indian tech startup with the government's backing has unveiled the first full-stack quantum computing system in India, marking a significant moment in the nation's advanced research and deep-tech journey and bringing the rapidly expanding Asian economy a step closer to achieving technological self-reliance. During the recent World Quantum Day, Bengaluru-based startup QpiAI introduced QpiAI-Indus, a quantum computer with no equals in India, and propelled the country to the top echelons of quantum computing research. Currently the most powerful quantum computing system in the country, QpiAI-Indus was developed under a government initiative dubbed the National Quantum Mission (NQM), which has…

Continue Reading

FridayApr 25, 2025 11:15 am

D-Wave Quantum Inc. (NYSE: QBTS) and Japan Tobacco Complete Quantum AI Project Designed to Improve Drug Discovery Outcomes

D-Wave and Japan Tobacco’s pharmaceutical division completed a proof-of-concept project aimed at speeding up and improving the design of small molecule pharmaceuticals.  D-Wave’s annealing quantum computer was used to train large language models within Japan Tobacco’s AI framework. The quantum-hybrid application outperformed classical methods in generating valid and drug-like molecules. Japan Tobacco plans to further pursue Quantum AI in molecular design following these early results. D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the pharmaceutical division of Japan Tobacco Inc. (“JT”), have announced the successful completion of a proof-of-concept project applying quantum computing…

Continue Reading

Contact us: (512) 354-7000